1.50 (-%)
As of Nov 21, 2024
Source:
Anebulo Pharmaceuticals, Inc is a clinical-stage biotechnology company developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (“ACI”) and the broader landscape of acute cannabis-induced conditions.
| Country | United States |
| Headquarters | lakeway, texas |
| Phone Number | 737 203 5270 |
| Industry | manufacturing |
| CEO | Richard Anthony Cunningham |
| Website | www.anebulo.com |